← Back to Search

Instagram Video Ads for Depression

N/A
Recruiting
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1: within 10 minutes of viewing the ad
Awards & highlights

Study Summary

This trial aims to test if short video messages can help reduce stigma & encourage depression treatment-seeking in teens. #mentalhealth

Who is the study for?
This trial is for English-speaking teenagers living in the US, aged between 14 and 18 years old. There are no specific exclusion criteria mentioned, so it appears open to all adolescents within this age range.Check my eligibility
What is being tested?
The study is examining how different types of short selfie videos shared on Instagram can help reduce stigma around depression among teens and encourage them to seek treatment if needed.See study design
What are the potential side effects?
Since this trial involves watching video ads rather than medical interventions, there are no direct physical side effects. However, participants may experience emotional or psychological responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1: within 10 minutes of viewing the ad
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1: within 10 minutes of viewing the ad for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement composite
Secondary outcome measures
Clicks on designated link

Trial Design

3Treatment groups
Active Control
Group I: DepressionActive Control1 Intervention
Adolescent depression
Group II: Depression, adjustedActive Control1 Intervention
Adolescent depression, impacted by racism
Group III: ControlActive Control1 Intervention
Control condition

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,851 Previous Clinical Trials
2,728,366 Total Patients Enrolled
63 Trials studying Depression
10,646 Patients Enrolled for Depression

Media Library

Control Clinical Trial Eligibility Overview. Trial Name: NCT05755165 — N/A
Depression Research Study Groups: Depression, Depression, adjusted, Control
Depression Clinical Trial 2023: Control Highlights & Side Effects. Trial Name: NCT05755165 — N/A
Control 2023 Treatment Timeline for Medical Study. Trial Name: NCT05755165 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an age ceiling for recruitment into this investigation?

"This research is enrolling individuals aged 14 through 18 years old."

Answered by AI

Is it possible to participate in this research initiative?

"To meet the eligibility criteria, individuals must have a diagnosis of depression and be between 14 and 18 years old. This research program is recruiting 10000 participants in total."

Answered by AI

Are there any unfilled vacancies for participants in this experiment?

"Affirmative. Information available on clinicaltrials.gov confirms that this trial, which was originally published April 1st 2023, is actively seeking participants for enrollment. A total of 10000 patients need to be recruited from two specific medical centres."

Answered by AI

How many participants are currently engaged in this trial program?

"Indeed, the clinicaltrials.gov website provides evidence that this medical trial is still enrolling participants. It was published on April 1st 2023 and its latest update occured 28 days later. In total, 10000 people are expected to be recruited from 2 different sites."

Answered by AI
~6667 spots leftby Mar 2025